Composition
- Active ingredients
- LETROZOLE 2.5MG; RIBOCICLIB SUCCINATE EQ 200MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA209935.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Kisqali Femara Co-Pack (Copackaged)
- Active substance
- letrozole
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Novartis
- Status
- Prescription
- FDA approval
- 4 May 2017
- Application
- NDA209935-001